An Open, Non-Comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan.
Phase of Trial: Phase IV
Latest Information Update: 30 Mar 2012
At a glance
- Drugs Amoxicillin/clavulanic acid (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 20 Feb 2010 Actual end date (Mar 2005) added as reported by ClinicalTrials.gov.
- 27 May 2009 New trial record